相关实验视频
Updated: Jun 10, 2025

06:08
A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
23.3K
在患有原发性阿尔多斯特主义的患者中,卡普托普里尔挑战测试定义的终极阳性和边界范围组之间的目标器官损伤的差异
Naoki Fujiwara1, Tatsuya Haze2,3,4, Hiromichi Wakui1
1Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
概括
日本的原发性阿尔多斯特隆症指南包括一个"边界范围". 这项研究发现,与绝对阳性组不同,边界组与负面结果相比没有显著的目标器官损伤.
科学领域:
- 内分泌学 在内分泌学.
- 高血压研究 高血压研究
- 临床诊断 临床诊断 临床诊断
背景情况:
- 日本对原发性阿尔多斯特主义的新指导方针定义了一个
- 边界范围的范围范围范围的范围范围.
- 对于功能确认性测试,这一类别在国际指南中并不常见.
- 这一边缘群体的临床意义和特征尚不清楚.
研究的目的:
- 为了调查目标器官损伤的患者被归类在该类别内的患者.
- 边界范围的范围范围范围的范围范围.
- 进行一次性阿尔多斯顿性质的确认测试.
- 通过日本初级阿尔多斯特罗尼斯研究II (JPAS-II) 的数据,将边界组与最终阳性和阴性组进行比较.
主要方法:
- 基于captopril-challenge测试结果的JPAS-II注册表中的1785名患者的分析.
- 从放射性免疫试验和化学发光酶免疫试验对血中阿尔多素度值的标准化,以一种共同的测定原理.
- 用多变量调整的模型来评估目标器官损伤的几率比率.
主要成果:
- 与消极组相比,最终阳性组的慢性病 (OR 2.01) 和心电图异常 (OR 1.66) 的几率明显更高.
- 边界和负组之间没有发现慢性病 (OR 0.73) 或心电图异常 (OR 1.01) 的显著差异.
- 观察到目标器官损伤患病率的线性增加,随着阿尔多与宁比率在卡普托普里尔挑战后的上升.
结论:
- 这是一个很棒的节目,这是一个很棒的节目.
- 边界范围的范围范围范围的范围范围.
- 在日本的原发性阿尔多斯特隆症指导方针中,这似乎与显著的目标器官损伤无关.
- 这些发现表明需要重新考虑这个临时建立的边界类别的临床意义.
- 这项研究强调了阿尔多素水平与目标器官损伤之间的持续关系.
相关概念视频
Adrenal Gland Disorders
1.4K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
1.4K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
394
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
394
Antihypertensive Drugs: Direct Renin Inhibitors
505
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
505
Hypertension III: Clinical Manifestations and Diagnostic Studies
3
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
3
Antihypertensive Drugs: Action of β1 Blockers
311
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
311
Antihypertensive Drugs: Potassium-Sparing Diuretics
469
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
469

